Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

SUN-101/eFlow for the Treatment of Chronic Obstructive Pulmonary Disease

Drug (Brand/Generic)

SUN-101 (glycopyrrolate)

Therapy Class

Long acting muscarinic antagonist

Current Indication

Chronic obstructive pulmonary disease

Market Sector

Respiratory

Development Status

NDA under review in the US

Developer

Sunovion Pharmaceuticals
Expand

Go Top